Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

Patients’ Preferences for Ways to Communicate Benefits of Cardiovascular Medication

Felicity Goodyear-Smith, Timothy Kenealy, Susan Wells, Bruce Arroll and Margaret Horsburgh
The Annals of Family Medicine March 2011, 9 (2) 121-127; DOI: https://doi.org/10.1370/afm.1193
Felicity Goodyear-Smith
MB, ChB, MGP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: f.goodyear-smith@auckland.ac.nz
Timothy Kenealy
MB, ChB, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Wells
MB, ChB, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Arroll
MB, ChB, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret Horsburgh
MA, EdD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Ranks assigned to modes of risk communication (from1=most to 5=least).

Tables

  • Figures
  • Additional Files
    • View popup
    Table 1

    Description of Participants (N = 934)

    Variablen%
    Sex
     Male47751.1
     Female45748.9
    Ethnicity
     European/other69374.2
     Māori727.7
     Pacific Islander555.9
     Asian11412.2
    Age range, y
     31–40444.7
     41–5019921.3
     51–6027329.2
     61–7023725.4
     >7018119.4
    Highest education
     Primary424.5
     Secondary46449.7
     Technical18820.1
     University24025.7
    Numeracy score
     0859.1
     120121.5
     230632.8
     334236.6
    Social deprivation of domicile
     1 (least deprived)24926.7
     221422.9
     316617.8
     411011.8
     5 (most deprived)16617.8
     Missing293.1
    • View popup
    Table 2

    Participant’s Rankings for Numerical Explanatory Modes That Would Encourage Them to Take Medication and Help Them to Make a Decision (N = 934)

    Would Encourage to Take MedicationWould Help to Make a Decision
    ModeRanked 1st n (%)Reversed Rank SumaRanked 1st n (%)Reversed Rank Suma
    Relative risk reduction605 (64.8)4,042603 (64.5)3,988
    Absolute risk107 (11.5)3,040131 (14.0)3,149
    Natural frequencies103 (11.0)2,08091 (9.7)1,989
    Odds85 (9.1)2,70676 (8.1)2,668
    Number needed to treat32 (3.4)2,13632 (3.4)2,213
    • ↵a Reversed rank sum is the sum of rank scores after they have been reversed so that rank 1 is given a value of 5, rank 2 is given a value of 4, and so on.

    • View popup
    Table 3

    Participant Responses to Other Questionnaire Items (N = 934)

    ItemMean (SD)a
    Concern about a heart attack4.1 (2.5)
    Perceived likelihood of a heart attack3.7 (2.4)
    Keenness to take medication7.0 (3.3)
    n (%)
    Prefer pictures to numbers516 (55.2)
    Prefer people chart to bar graph468 (50.1)
    Prefer positively framed to negatively framed statement650 (69.6)
     No preference211 (22.6)
    Prefer doctor to give opinion rather than explain using numbers and/or pictures577 (61.8)
     No preference12 (1.3)
    • ↵a Scored on a 10-point scale in which 1 = least concern/perceived likelihood/ keenness, and 10 = most concerned/perceived likelihood/keenness.

    • View popup
    Table 4

    Linear Regressions of Associations With Keenness to Take Medication and With Perceived Likelihood of Having Heart Attack

    AssociationCoefficientP Value
    Associations with keenness to take medicationa
     Calculated cardiovascular disease risk0.38.01
     Perceived likelihood of heart attack0.35<.001
     Primary school education only1.38.02
     Older age0.31.02
    Associations with perceived likelihood of having a heart attackb
     Calculated cardiovascular disease risk0.40<.001
     Numeracy−0.28.002
     Education level−0.25<.001
     Māori1.130.002
     Concern about heart attack0.220.001
    • ↵a n=928; R2=0.16.

    • ↵b n=927; R2=0.17.

    • View popup
    Table 5

    Comparing Groups by First-Ranked Responses For Mode of Risk Communication That Would Most Encourage Them to Take Medication

    Explanatory Mode Compared With RRRCoefficientP Value
    Absolute risk reduction
    Numeracy−0.11.14
    Follows horse racing0.02.96
    Prefer pictures to numbers−0.14.27
    Concern about heart attack−0.04.34
    Pacific Islander0.10.58
    Asian0.66.003
    Natural frequencies
    Numeracy−0.34.002
    Follows horse racing0.89<.001
    Prefer pictures to numbers0.60.02
    Concern about heart attack−0.07.23
    Pacific Islander1.55<.001
    Asian1.44<.001
    Odds
    Numeracy−0.07.40
    Follows horse racing0.53<.001
    Prefer pictures to numbers−0.39.09
    Concern about heart attack−0.15<.001
    Pacific Islander0.33.38
    Asian−0.04.77
    Number needed to treat
    Numeracy−0.05.64
    Follows horse racing0.91<.001
    Prefer pictures to numbers−0.27.12
    Concern about heart attack−0.14.05
    Pacific Islander0.47.38
    Asian0.75.18
    • RRR=relative risk reduction.

    • Note: Multinomial logistic regression with first preference for relative risk taken as the reference group (n = 880, pseudo R2=0.05).

Additional Files

  • Figures
  • Tables
  • Supplemental Appendix

    Supplemental Appendix. The Questionnaire, Using the Example Given to Patients at Approximately 15% 5-year Risk of a Cardiovascular Event

    Files in this Data Supplement:

    • Supplemental data: Appendix - PDF file, 6 pages, 459 KB
  • The Article in Brief

    Patients' Preferences for Ways to Communicate Benefits of Cardiovascular Medication

    Felicity Goodyear-Smith , and colleagues

    Background This study examined patient preferences for ways in which doctors communicate the benefits of taking medication to prevent cardiovascular disease.

    What This Study Found Patients prefer a doctor give his or her opinion about the medication rather than explain the risks using numbers or pictures. Moreover, patients prefer visual depictions to words. Specifically, the study of 934 patients in Auckland, New Zealand, found 62 percent preferred to know what their doctor thinks about the medication, and 55 percent preferred pictorial presentations to numbers. Patients showed a strong preference for relative risk as a means of encouraging them to take preventive medication.

    Implications

    • Patients� willingness to take preventive cardiovascular medication depends more on the way in which treatment benefit is communicated than on their cardiovascular disease risk score or level of concern about a future cardiovascular episode.
    • It is not possible to predict which mode of communication individual patients will prefer. As a result, the authors recommend clinicians use several methods and formats to communicate risk, matching information to the needs of individuals.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 9 (2)
The Annals of Family Medicine: 9 (2)
Vol. 9, Issue 2
March/April 2011
  • Table of Contents
  • Index by author
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Patients’ Preferences for Ways to Communicate Benefits of Cardiovascular Medication
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Patients’ Preferences for Ways to Communicate Benefits of Cardiovascular Medication
Felicity Goodyear-Smith, Timothy Kenealy, Susan Wells, Bruce Arroll, Margaret Horsburgh
The Annals of Family Medicine Mar 2011, 9 (2) 121-127; DOI: 10.1370/afm.1193

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Patients’ Preferences for Ways to Communicate Benefits of Cardiovascular Medication
Felicity Goodyear-Smith, Timothy Kenealy, Susan Wells, Bruce Arroll, Margaret Horsburgh
The Annals of Family Medicine Mar 2011, 9 (2) 121-127; DOI: 10.1370/afm.1193
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgements
    • Footnotes
    • REFERENCES
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Inaccurate Risk Perceptions and Individualized Risk Estimates by Patients with Type 2 Diabetes
  • Government's plans for universal health checks for people aged 40-75
  • In This Issue: Back to Basics: Talking, Listening, and Low-Tech Primary Care
  • Google Scholar

More in this TOC Section

  • Shared Decision Making Among Racially and/or Ethnically Diverse Populations in Primary Care: A Scoping Review of Barriers and Facilitators
  • Convenience or Continuity: When Are Patients Willing to Wait to See Their Own Doctor?
  • Feasibility and Acceptability of the “About Me” Care Card as a Tool for Engaging Older Adults in Conversations About Cognitive Impairment
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Prevention
  • Methods:
    • Quantitative methods
  • Other topics:
    • Communication / decision making

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine